A common enemy for Democrats, Republicans and patients

OP / ED

Democrats have a golden opportunity to lower drug prices — again — before the next Congress begins on January 3.

Democrats and Republicans alike support two bills that’d rein in pharmacy benefit managers — the gigantic and secretive “pharmaceutical middlemen who squeeze small pharmacies’ profits and raise costs for consumers,” as Vice President Kamala Harris described them during the campaign. If congressional leaders bring the bills up for a vote during the post-election lame duck session, they’ll almost certainly pass — and thus save Americans billions of dollars at the pharmacy.